Citation Formats
An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ö. G. SEVİNDİK Et Al. , "An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy," 18th International Myeloma Workshop , VİYANA, Austria, pp.258, 2021

SEVİNDİK, Ö. G. Et Al. 2021. An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy. 18th International Myeloma Workshop , (VİYANA, Austria), 258.

SEVİNDİK, Ö. G., ÖZKURT, Z. N., BOĞA, C., KALAYOĞLU BEŞIŞIK, S., İPEK, Y., GEDÜK, A., ... HARMANDALI, A.(2021). An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy . 18th International Myeloma Workshop (pp.258). VİYANA, Austria

SEVİNDİK, ÖMÜR Et Al. "An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy," 18th International Myeloma Workshop, VİYANA, Austria, 2021

SEVİNDİK, ÖMÜR G. Et Al. "An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy." 18th International Myeloma Workshop , VİYANA, Austria, pp.258, 2021

SEVİNDİK, Ö. G. Et Al. (2021) . "An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy." 18th International Myeloma Workshop , VİYANA, Austria, p.258.

@conferencepaper{conferencepaper, author={ÖMÜR GÖKMEN SEVİNDİK Et Al. }, title={An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy}, congress name={18th International Myeloma Workshop}, city={VİYANA}, country={Austria}, year={2021}, pages={258} }